Yuri Takashi, Danbara Naoyuki, Tsujita-Kyutoku Miki, Fukunaga Kenji, Takada Hideho, Inoue Yoshikazu, Hada Takahiko, Tsubura Airo
Department of Pathology, Kansai Medical University, Moriguchi, Osaka 570-8506, Japan.
Nutr Cancer. 2003;45(2):211-7. doi: 10.1207/S15327914NC4502_11.
We compared the effects of identical amounts but different proportions of dietary n-3 polyunsaturated fatty acids (PUFAs) on N-methyl-N-nitrosourea (MNU)-induced mammary cancer in a rat model. The ability of dietary docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) to suppress mammary cancer was evaluated. Female Sprague-Dawley rats were randomly assigned to three groups and maintained on diets containing 10% fatty acid consisting of EPA, a 1:1 mixture of EPA-plus-DHA, or DHA. The experimental diet was started after administration of MNU at 49 days of age, and the rats were maintained on the respective diets until the largest mammary tumor reached >1 cm in diameter or until the end of the study period (20 wk after MNU). All histologically detected mammary carcinomas were evaluated, irrespective of size. The DHA diet was associated with significant suppression of the carcinogenic effect of MNU compared with the EPA and EPA-plus-DHA diets: tumor incidence decreased to 23% (3/13) compared with 73% (11/15) and 65% (12/17) (P < 0.01 and P < 0.05, respectively); tumor multiplicity decreased to 0.23 compared with 1.67 and 1.59 (P < 0.01 and P < 0.05, respectively). There was no significant difference in tumor latency among the DHA, EPA, and EPA-plus-DHA groups (119, 105, and 117 days, respectively). Over 20 wk, the fatty acid composition of serum and mammary fat tissue reflected differences in the dietary n-3 PUFAs. Although DHA suppressed MNU-induced mammary carcinogenesis more effectively than EPA, generalized steatosis including mammary fat tissue appeared in all three groups.
我们在大鼠模型中比较了等量但不同比例的膳食n-3多不饱和脂肪酸(PUFA)对N-甲基-N-亚硝基脲(MNU)诱导的乳腺癌的影响。评估了膳食二十二碳六烯酸(DHA)和二十碳五烯酸(EPA)抑制乳腺癌的能力。将雌性斯普拉格-道利大鼠随机分为三组,分别给予含10%脂肪酸的饮食,脂肪酸分别为EPA、EPA与DHA的1:1混合物或DHA。在49日龄给予MNU后开始实验饮食,大鼠持续食用各自的饮食,直到最大的乳腺肿瘤直径超过1 cm或直到研究期结束(MNU给药后20周)。对所有组织学检测到的乳腺癌进行评估,无论其大小。与EPA和EPA加DHA饮食相比,DHA饮食与MNU致癌作用的显著抑制相关:肿瘤发生率降至23%(3/13),而EPA组和EPA加DHA组分别为73%(11/15)和65%(12/17)(P分别<0.01和P<0.05);肿瘤多发性降至0.23,而EPA组和EPA加DHA组分别为1.67和1.59(P分别<0.01和P<0.05)。DHA、EPA和EPA加DHA组之间的肿瘤潜伏期无显著差异(分别为119、105和117天)。在20周内,血清和乳腺脂肪组织的脂肪酸组成反映了膳食n-3多不饱和脂肪酸的差异。尽管DHA比EPA更有效地抑制MNU诱导的乳腺致癌作用,但所有三组均出现包括乳腺脂肪组织在内的全身性脂肪变性。